The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer

Journal of Hematology and Oncology

Volumn 5, Issue , 2012, Pages

  Labbaye, Catherine ^a   Testa, Ugo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 146A; MICRORNA; MIRN146 MICRORNA, HUMAN;

CELL DIFFERENTIATION; GENE EXPRESSION; GENE TARGETING; HEMATOPOIESIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; NEOPLASM; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SOLID TUMOR; ANIMAL; GENETICS; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL DIFFERENTIATION; GENES, TUMOR SUPPRESSOR; HEMATOPOIESIS; HUMANS; IMMUNE SYSTEM; IMMUNITY; MICRORNAS; NEOPLASMS;

EID: 84858847737     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-5-13     Document Type: Review

References (60)

1. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, Hammond SM, Genes Dev 2006 20 2202 2207 10.1101/gad.1444406 16882971
2. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Taganov KD, Boldin MP, Chang KJ, Baltimore D, Proc Natl Acad Sci USA 2006 103 12481 12486 10.1073/pnas.0605298103 16885212 (Pubitemid 44267285)
3. MicroRNA-146a feedback inhibits RIG-1-dependent type I IFN production in macrophage by targeting TRAF6, IRAK1 and IRAK2. Hou J, Wang P, Liu L, Liu X, Ma F, An H, Wang Z, Cao X, J Immunol 2009 183 2150 2158 10.4049/jimmunol.0900707 19596990
4. Rapid changes in microRNA-146a expression negatively regulate the IL-1-induced inflammatory response in human lung alveolar epithelial cells. Perry MM, Maschos SA, Williams AE, Shapard NJ, Larner-Svensson H, Lindsay MA, J Immunol 2008 180 5689 5698 18390754
5. CCL8/MCP-2 is a target for miR-146a in HIV1-infected human microglial cells. Rom S, Rom I, Passiatore G, Pacifici M, Radhakrishnan S, Del Valle L, Pina-Oveido S, Khalili K, Eletto D, Peruzzi F, FASEB J 2010 24 2292 2300 10.1096/fj.09-143503 20181935
6. An emerging player in the adptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Curtale G, Citarella F, Carissimi C, Goldoni M, Carussi N, Fulci V, Franceschini D, Meloni F, Barnaba V, Macino G, Blood 2010 115 265 273 10.1182/blood-2009-06-225987 19965651
7. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidja KS, Welch DR, Cancer Res 2009 69 1279 1283 10.1158/0008-5472.CAN-08-3559 19190326
8. miR-146a suppresses invasion of pancreatic cancer cells. Li Y, VandenBoom T II, Wang Z, Kong D, Ali S, Philip P, Sarkar F, Cancer Res 2010 70 1486 1495 10.1158/0008-5472.CAN-09-2792 20124483
9. Clinical significance of miR-146a in gastric cancer cases. Kogo R, Mimori K, Tanaka F, Komune S, Mori M, Clin Cancer Res 2011 17 4277 4284 10.1158/1078-0432.CCR-10-2866 21632853
10. Loss of miR-146a function in hormone-refractory prostate cancer. Lin SL, Chiang A, Chang D, Ying SY, RNA 2008 14 417 424 10.1261/rna.874808 18174313 (Pubitemid 351397806)
11. MicroRNA-146a inhibits glioma development by targeting Notch1. Mei J, Bacho R, Zhang CL, Mol Cell Biol 2011 31 3584 3592 10.1128/MCB.05821-11 21730286
12. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Labbaye C, Spinello I, Quaranta MT, Pelosi E, Pasquini L, Petrucci E, Biffoni M, Nuzzolo ER, Billi M, Fo R, Brunetti E, Grignani F, Testa U, Peschle C, Nat Cell Biol 2008 10 788 800 10.1038/ncb1741 18568019 (Pubitemid 351927708)
13. miR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. Sun S, Zheng B, Han M, Fang X, Li H, Miao S, Su M, Han Y, Shi H, Wen JK, EMBO Rep 2011 12 56 62 10.1038/embor.2010. 172 21109779
14. Expression of microRNA-146 suppresses NF-kB activity with reduction of metastatic potential in breast cancer cells. Bhamik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC, Oncogene 2008 27 5643 5647 10.1038/onc.2008.171 18504431
15. Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuroregulin-ErbB pathway. Horie T, Ono K, Nishi H, Nagao K, Kinoshita M, Watanabe S, Kuwabara Y, Nakashima Y, Takanabe-Mori R, Nishi E, Hasagawa K, Kita T, Kimura T, Card Res 2010 87 656 664 10.1093/cvr/cvq148
16. Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a. Punji V, Matta H, Schamus S, Tamewitz A, Anyang B, Chaudhary PM, Oncogene 2010 29 1835 1844 10.1038/onc.2009.460 20023696
17. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Lu LF, Boldin MP, Chaudry A, Taganov KD, Hanada T, Yoshimura A, Baltimore D, Rudensky AK, Cell 2010 142 914 929 10.1016/j.cell.2010.08.012 20850013
18. miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. Nahid MA, Paulei KM, Satoh M, Chan EKL, J Biol Chem 2009 50 34590 34599
19. Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. Nahid MA, Satoh M, Chan EK, J Immunol 2011 186 1723 1734 10.4049/jimmunol.1002311 21178010
20. miR-146a is differentially expressed by myeloid dendritic cell subsets and desensitizes cells to TLR2-dependent activation. Jurkin J, Schichl YM, Koeffel R, Bauer T, Richter S, Konradi S, Gesslbauer B, Strobl H, J Immunol 2010 184 4955 4965 10.4049/jimmunol.0903021 20375304
21. Macrophage development from HSCs requires PU.1-coordinated microRNA expression. Ghany S, Riemke P, Schonheit J, Lenze D, Stumm J, Hoogenkamp M, Lagerdijk A, Heinz S, Bonifer C, Baskkers J, Adbeliah-Seyfried S, Hummel M, Rosenbauer F, Blood 2011 118 2275 2284 10.1182/blood-2011-02-335141 21730352
22. miR-146q is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. Boldin MP, Teganov KD, Rao DJ, Yang L, Zhao JL, Kalwani M, Garcia-Flores Y, Luong M, Devrekanli A, Xu J, Sun G, Tay J, Lusley PS, Baltimore D, J Exp Med 2011 208 1189 1201 10.1084/jem.20101823 21555486
23. NF-kB dysregulation in microRNAa-deficient mice drives the development of myeloid malignancies. Zhao JL, Rao DS, Boldin MP, Taganov KD, O'Connell RM, Baltimore D, Proc Natl Acad Sci USA 2011 108 9184 9189 10.1073/pnas.1105398108 21576471
24. MicroRNA-146a disrupts hematopoietic differentiation and survival. Starczynowski DT, Kuchenbauer F, Wegrzyn J, Rouhi A, Petriv O, Hansen CL, Humphreis RK, Karsan A, Exp Hematol 2011 39 167 178 10.1016/j.exphem.2010.09.011 20933052
25. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F, Fabbri M, Coombes K, Alder H, Nakamura T, Flomenberg N, Marcucci G, Calin GA, Kornblau SM, Kantarjian H, Bloomfield CD, Andreef M, Croce CM, Blood 2008 111 3183 3189 10.1182/blood-2007-07-098749 18187662
26. - syndrome phenotype. Starczynowski DT, Kukenbauer F, Arigiropoulos B, Sung S, Morin R, Muranyi A, Hogge D, Marra M, Wells RA, Buckenstein R, Lan W, Humphreis RK, Korsan A, Nature Med 2010 16 49 58 10.1038/nm.2054 19898489
27. MicroRNA expression in maturing megakaryocytes. Opalinska JB, Bersenev A, Zhang Z, Schumier AA, Choi J, Yao Y, D'Souza J, Tong W, Weiss MJ, Blood 2010 116 128 e138 10.1182/blood-2010-06-292920 20720187
28. MicroRNAs in platelet production and activation. Edelstein LC, Bray PF, Blood 2011 117 5289 5296 10.1182/blood-2011-01-292011 21364189
29. Deregulation of microRNA in myelodysplastic syndrome. Ryasen GW, Starczynowski DT, Leukemia 2012 26 13 22 10.1038/leu.2011.221 21852786
30. The clinical potential of microRNAs. Budhu A, Ji J, Wang X, J Hem Oncol 2010 3 37 10.1186/1756-8722-3-37
31. The role of microRNA genes in papillary thyroid carcinoma. He H, Jazdsewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu C, Franssila K, Suster S, Kloos RT, Croce CM, De la Chapelle A, Proc Natl Acad Sci USA 2005 102 19075 19080 10.1073/pnas.0509603102 16365291 (Pubitemid 43049568)
32. A common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Jazdewski K, Murray EL, Franssila K, Jarkab B, Schoenberg DR, De La Chapelle A, Proc Natl Acad Sci USA 2008 105 7269 7274 10.1073/pnas.0802682105 18474871 (Pubitemid 351754467)
33. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Jazdewski K, Liyannrachchi S, Swierniak M, Pachucki J, Ringel MD, Jarzab B, De La Chapelle A, Proc Natl Acad Sci 2009 106 1502 1505 10.1073/pnas.0812591106 19164563
34. MicroRNA in thyroid cancer. De La Chapelle A, Jazdewski K, J Clin Endocrinol Metab 2011 96 3326 3336 10.1210/jc.2011-1004 21865360
35. Nuclear factor- {kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a. Pacifico F, Crescenzi E, Mellone S, Iannetti A, Pomino N, Liguoro D, Moscato F, Grieco M, Formisano S, Leonardi A, J Clin Endocrinol Metab 2010 95 1421 1430 10.1210/jc.2009-1128 20061417
36. MiR-146a and human disease. Li L, Chen XP, Li Y, Scand J Immunol 2010 71 227 231 10.1111/j.1365-3083.2010.02383.x 20384865
37. Micro RNA alterations of pancreatic intraepithelial neoplasms (PanINs). Yu J, Li A, Hong SM, Hruban RH, Goggins M, Cancer Res 2012 18 981 992 10.1158/1078-0432.CCR-11-2347
38. Curcumin analog CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating E2H2 expression. Bao B, Ali S, Benerjee S, Wang Z, Logne F, Azmi AS, Kong D, Ahmad A, Li Y, Padhye S, Sarkar FH, Cancer Res 2011 72 335 345 22108826
39. MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis. Hou Z, Xie L, Yu L, Qian X, Liu B, Med Oncol 2011
40. Up-regulated microRNA-146a negatively modulates Helicobactert pylori-induced inflammatory response in human gastric epithelial cells. Liu Z, Xiao B, Tang B, Li B, Zhu E, Guo G, Gu J, Zhuang Y, Liu X, Ding H, Zhao X, Guo H, Mao X, Zou Q, Microbes Infect 2010 12 854 863 10.1016/j.micinf.2010.06.002 20542134
41. H. pylori related proinflammatory cytokines contribute to the induction of miR-146a in human gastric epithelial cells. Li N, Xu X, Xiao B, Zhu ED, Li BS, Liu Z, Tang B, Zou QM, Liang HP, Maop XH, Mol Biol Rep 2011
42. Expression of micro-RNA 146 suppresses NF-kB activity with reduction of metastatic potential in breast cancer cells. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC, Oncogene 2008 27 5643 5647 10.1038/onc.2008.171 18504431
43. Glioma display a microRNA expression profile reminiscent of neural precursor cell. Lavon I, Zrihan D, Granit A, Einstein O, Fainstein N, Cohen MA, Zelikovitch, Shoshan Y, Spektor S, Reubinoff BE, Felig Y, Geritz O, Ben-Hur T, Siegal T, Neurol Oncol 2010 12 422 433
44. A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma. Permuth-Wey J, Thompson RC, Burton Nabors L, Olson JJ, Browning JE, Modden MH, Ann Chen Y, Egan KM, J Neuropharmacol 2011 105 639 646
45. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM, PLoS One 2008 3 2557 10.1371/journal.pone.0002557 18596939
46. Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Visone R, Rassenti LZ, Veronese A, Taccioli C, Costinean S, Aguda BD, Volinia S, Ferracin M, Palatini J, Balatti V, Alder H, Negrini M, Kipps JJ, Croce CM, Blood 2009 114 3872 3879 10.1182/blood-2009-06-229211 19717645
47. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Garzon R, Volinia S, Liu CG, Cymering CF, Palumbo T, Bloomfield C, Andreef M, Croce CM, Blood 2008 111 3183 3189 10.1182/blood-2007- 07-098749 18187662
48. Expression profiling of cytogenetically normal AML identifies microRNAs that target genes involved in monocytic differentiation. Lutherborrow M, Bryant A, Jayaswal V, Am J Hematol 2011 86 2 11 10.1002/ajh.21864 20981674
49. Micro RNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias. Spinello I, Quaranta MT, Riccioni R, Riti V, Pasquini L, Boe A, Pelosi E, Vitale A, Fo R, Testa U, Labbaye C, Blood Cancer Journal 2011 1 26 10.1038/bcj.2011.24
50. Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Starczynovski DT, Morin R, McPherson A, Lam J, Chafi R, Wegzyn J, Kuckenbauer F, Hirst M, Tohyama K, Humphreis K, Lam WL, Marra M, Karsan A, Blood 2011 117 595 607 10.1182/blood-2010-03-277012 20962326
51. Targeting of Smad 4 links microRNA-146a to the TGFbeta pathway during retinoic acid induction in acute promyelocytic leukemia cell line. Zhang H, Wang HR, Yang S, Wang T, Wang C, Chen FY, Int J Hematol 2010 92 129 135 10.1007/s12185-010-0626-5 20577838
52. - syndrome. Votivova A, Gronanova M, Merkerova MD, Belikova M, Vasikova A, Neuwirtova R, Cernak J, J Hemat Oncol 2011 4 1 10.1186/1756-8722-4-1
53. p53 represses c-Myc through induction of the tumor suppressor miR-145. Sachdeva M, Zhu S, Wu F, Proc Natl Acad Sci USA 2009 106 3207 3212 10.1073/pnas.0808042106 19202062
54. - syndrome. Boultwood J, Pellegatti A, McKenzie AN, Wainscoat JS, Blood 2010 116 5803 5811 10.1182/blood-2010-04-273771 20733155
55. Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Flamant S, Ritchie W, Guilhot J, Holst J, Bonnet ML, Chomel JC, Guilhot F, Turhan A, Rasko J, Haematologica 2010 95 1325 1333 10.3324/haematol.2009.020636 20460641
56. MicroRNA-146a downregulates NFkB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Paik J, Jang JY, Jeon YK, Kim WY, Kim TM, Heo DS, Kim CW, Clin Cancer Res 2011 17 4761 4771 10.1158/1078-0432.CCR-11-0494 21610143
57. MicroRNA miR-146a and farther oncogenesis-related cellular microRNA are dysregulated in HTLV1-transformed T lymphocytes. Pichler K, Schneider G, Grassmann R, Retrovirology 2008 5 100 10.1186/1742-4690-5-100 19014482
58. MicroRNA miR-146a is induced by HTLV-1 tax and increases the growth of HTLV-1-infected T-cells. Tomita M, Tanaka Y, Mori N, Int J Cancer 2010
59. Epstein-Barr virus-encoded latent membrane protein1 (LMP1) induces the expression of the cellular microRNA miR-146a. Motsch N, Pfuhl T, Marazek J, Barth S, Grasser FA, RNA Biol 2007 4 131 137 10.4161/rna.4.3.5206 18347435 (Pubitemid 351237914)
60. Epstein-Barr virus latent membrane protein 1 induces cellular microRNA-146a, a modulator of lymphocyte signaling pathways. Cameron JE, Yiu Q, Fewell C, Lacey M, Mc Bride J, J Virol 2008 82 1946 1958 10.1128/JVI.02136-07 18057241 (Pubitemid 351206940)